Xml Financial, LLC Repligen Corp Transaction History

Xml Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$140.68 - $188.02 $42,204 - $56,406	300 Added 0.44%	68,478 $2.53 Million
Q2 2021 Aug 10, 2021	BUY	$165.87 - $220.95 $51,751 - $68,936	312 Added 0.46%	68,178 $3.05 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $345,110 - $445,846	2,817 Added 4.33%	67,866 $2.21 Million
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $26,167 - $33,615	308 Added 0.48%	65,049 $1.17 Million
Q4 2019 Feb 04, 2020	BUY	$73.84 - $93.08 $4.78 Million - $6.03 Million	64,741 New	64,741 $1.1 Million

482

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.04B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Xml Financial, LLC with notifications on news.